State Street Corp Synaptogenix, Inc. Transaction History

State Street Corp

  • $2.25 Trillion
  • Q2 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
BUY
$6.31 - $10.09 $7,571 - $12,108
1,200 Added 6.35%
20,100 $156,000
Q4 2021

Feb 14, 2022
BUY
$8.38 - $13.72 $158,382 - $259,308
18,900 New
18,900 $161,000

Others Institutions Holding SNPX

# of Institutions
1
Shares Held
30K
Call Options Held
0
Put Options Held
0
View Full List

About Synaptogenix, Inc.

SNPX Quotes by TradingView
  • Ticker SNPX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 6,840,630
  • Market Cap $20.2M
  • Description
  • Synaptogenix, Inc. operates as a biopharmaceutical company with product candidates in pre-clinical and clinical development. It focuses on developing a product platform based upon a drug candidate called Bryostatin-1 for the treatment of Alzheimer's disease. The company is also evaluating therapeutic applications of bryostatin for other neurodeg...
More about SNPX
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email